Organised by:
Supported by:
SCIENTIFIC SYMPOSIUM
Shaping a Brighter Future:
Real-World Insights to Transform Lung Cancer Treatment with IO Therapy
2025
THU
10 JULY
18:30-20:30 (HKT)
Ming II, 4/F, Sheraton Hong Kong Hotel & Towers, 20 Nathan Rd, Tsim Sha Tsui
EVENT RECORDING
00:00
02:28
30:41
52:19
Introduction
Prof. CHU Tainting: Real-world insights to transform lung cancer treatment with IO therapy
Prof. Victor H.F. Lee: Local clinical experience sharing
Q&A and panel discussion
SPEAKERS
Prof. CHU Tianqing
Chief Physician, Department of Respiratory Medicine,
Director, Center for Clinical Research,
Shanghai Chest Hospital, affiliated to Shanghai Jiaotong University
Prof. Chu Tianqing currently serves as Chief Physician from the Department of Respiratory Medicine and Director of Center for Clinical Research at Shanghai Chest Hospital, affiliated to Shanghai Jiaotong University. She also serves as the Chairman of Thoracic Oncology Precision Treatment at the China Primary Health Care Foundation and a Council Member of the Chinese Society of Clinical Oncology (CSCO).
Prof. Chu specializes in the early diagnosis and personalized therapy for lung cancer, including early detection, drug resistance-related biomarkers, and individualized treatment. She has participated in multiple national research projects and international multi-center clinical trials, with publications on international journals.
Prof. Victor H.F. LEE
Clinical Professor,
Department of Clinical Oncology, The University of Hong Kong
Prof. Victor H.F. Lee is currently Clinical Professor of the Department of Clinical Oncology, The University of Hong Kong. He is also an active member of the Hong Kong Anti-Cancer Society Cancer Education Subcommittee.
His current interests include clinical and genetic studies on various cancer types, including lung cancers. In addition, he has a special interest in dosimetric studies on intensity-modulated radiation therapy, stereotactic radiosurgery, and selective internal radiation therapy. With extensive publications in cancer management and solid frontline experience in Hong Kong’s oncology landscape, today Prof. Lee will specifically share local clinical experience on the use of immunotherapy in non-small cell lung cancer.
AGENDA
TIME
TOPIC
CHAIRMAN/
SPEAKER(S)
18: 30 - 19:00
19:00 - 19:05
19:05 - 19:45
Reception
Welcome and opening remark
Real-world insights to transform lung cancer treatment with IO therapy
19:45 - 20:05
20:05 - 20:25
20:25 - 20:30
Local clinical experience sharing
Q&A and panel discussion
Closing remark
Dr. NYAW Shi Feng
Prof. CHU Tianqing
Prof. Victor H.F. LEE
All participants
Dr. NYAW Shi Feng
